Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19

Cardiac patients are at risk for a severe course of coronavirus infection, as treatments for COVID-19 may have side effects on the cardiovascular system. Also, patients with pre-existing cardiovascular diseases risk factors and cardiovascular diseases are among the most vulnerable, with a potentiall...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. N. Panina, V. I. Vishnevsky
Format: Article
Language:Russian
Published: Open Systems Publication 2022-03-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/895
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248539810463744
author Yu. N. Panina
V. I. Vishnevsky
author_facet Yu. N. Panina
V. I. Vishnevsky
author_sort Yu. N. Panina
collection DOAJ
description Cardiac patients are at risk for a severe course of coronavirus infection, as treatments for COVID-19 may have side effects on the cardiovascular system. Also, patients with pre-existing cardiovascular diseases risk factors and cardiovascular diseases are among the most vulnerable, with a potentially high risk of infection, cardiovascular events, and adverse outcomes. COVID-19 is associated with many direct and indirect cardiovascular complications. In this regard, we analyzed a large amount of literature in the CochraneLibrary, ScienceDirect, PubMed databases, summarized modern scientific data and identified the features of the management of cardiac patients during the COVID-19 pandemic. It has been noted that careful monitoring of highly sensitive troponin I and troponin T can aid in the early detection of cardiac damage and possibly prevent further deterioration with appropriate treatment. Elevated troponin is indicative of myocardial injury, which can be caused by cytokine storm, hypoxic injury, coronary spasm, microthrombi, myocarditis, or plaque rupture. Systemic inflammation and hypoxemia caused by COVID-19 may also contribute to the development of various types of arrhythmias. In addition, severe inflammation can cause hemostasis disorders, including disseminated intravascular coagulation, microclot formation in the lungs, and intravascular coagulopathy. An increase in troponin levels may be secondary to, and not due to, plaque instability. At the same time, to date, the strategy for managing cardiac patients during a pandemic is not clearly defined and is mainly focused on supportive therapy, as well as on the treatment of the infection itself.
format Article
id doaj-art-133b9def5d464ad7aefe3bd07e3d421c
institution Kabale University
issn 1560-5175
2687-1181
language Russian
publishDate 2022-03-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-133b9def5d464ad7aefe3bd07e3d421c2025-08-20T03:57:51ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812022-03-0103404310.51793/OS.2022.25.3.006890Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19Yu. N. Panina0V. I. Vishnevsky1Federal State Budgetary Educational Institution of Higher Education Orel State University named after I. S. Turgenev, Medical InstituteFederal State Budgetary Educational Institution of Higher Education Orel State University named after I. S. Turgenev, Medical InstituteCardiac patients are at risk for a severe course of coronavirus infection, as treatments for COVID-19 may have side effects on the cardiovascular system. Also, patients with pre-existing cardiovascular diseases risk factors and cardiovascular diseases are among the most vulnerable, with a potentially high risk of infection, cardiovascular events, and adverse outcomes. COVID-19 is associated with many direct and indirect cardiovascular complications. In this regard, we analyzed a large amount of literature in the CochraneLibrary, ScienceDirect, PubMed databases, summarized modern scientific data and identified the features of the management of cardiac patients during the COVID-19 pandemic. It has been noted that careful monitoring of highly sensitive troponin I and troponin T can aid in the early detection of cardiac damage and possibly prevent further deterioration with appropriate treatment. Elevated troponin is indicative of myocardial injury, which can be caused by cytokine storm, hypoxic injury, coronary spasm, microthrombi, myocarditis, or plaque rupture. Systemic inflammation and hypoxemia caused by COVID-19 may also contribute to the development of various types of arrhythmias. In addition, severe inflammation can cause hemostasis disorders, including disseminated intravascular coagulation, microclot formation in the lungs, and intravascular coagulopathy. An increase in troponin levels may be secondary to, and not due to, plaque instability. At the same time, to date, the strategy for managing cardiac patients during a pandemic is not clearly defined and is mainly focused on supportive therapy, as well as on the treatment of the infection itself.https://journal.lvrach.ru/jour/article/view/895cardiac patientspandemiccovid-19heart failuremyocardial infarctionatrial fibrillationmyocardial damagearterial hypertensionrisk of infection
spellingShingle Yu. N. Panina
V. I. Vishnevsky
Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19
Лечащий Врач
cardiac patients
pandemic
covid-19
heart failure
myocardial infarction
atrial fibrillation
myocardial damage
arterial hypertension
risk of infection
title Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19
title_full Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19
title_fullStr Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19
title_full_unstemmed Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19
title_short Features of management of cardiac patients during the pandemic of coronavirus infection COVID-19
title_sort features of management of cardiac patients during the pandemic of coronavirus infection covid 19
topic cardiac patients
pandemic
covid-19
heart failure
myocardial infarction
atrial fibrillation
myocardial damage
arterial hypertension
risk of infection
url https://journal.lvrach.ru/jour/article/view/895
work_keys_str_mv AT yunpanina featuresofmanagementofcardiacpatientsduringthepandemicofcoronavirusinfectioncovid19
AT vivishnevsky featuresofmanagementofcardiacpatientsduringthepandemicofcoronavirusinfectioncovid19